Jan Trka

10.7k total citations
149 papers, 3.7k citations indexed

About

Jan Trka is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, Jan Trka has authored 149 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Public Health, Environmental and Occupational Health, 88 papers in Hematology and 55 papers in Molecular Biology. Recurrent topics in Jan Trka's work include Acute Lymphoblastic Leukemia research (104 papers), Acute Myeloid Leukemia Research (59 papers) and Chronic Myeloid Leukemia Treatments (42 papers). Jan Trka is often cited by papers focused on Acute Lymphoblastic Leukemia research (104 papers), Acute Myeloid Leukemia Research (59 papers) and Chronic Myeloid Leukemia Treatments (42 papers). Jan Trka collaborates with scholars based in Czechia, Germany and Netherlands. Jan Trka's co-authors include Jan Starý, Jan Zuna, Markéta Žaliová, Ondřej Hrušák, Júlia Starková, Dirk Reinhardt, Eva Froňková, Marry M. van den Heuvel‐Eibrink, Ester Mejstříková and Rob Pieters and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Jan Trka

141 papers receiving 3.6k citations

Peers

Countries citing papers authored by Jan Trka

Since Specialization

Citations

This map shows the geographic impact of Jan Trka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Trka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Trka more than expected).

Fields of papers citing papers by Jan Trka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Trka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Trka. The network helps show where Jan Trka may publish in the future.

Co-authorship network of co-authors of Jan Trka

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Trka. A scholar is included among the top collaborators of Jan Trka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Trka. Jan Trka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NGS‐MRD negativity in post‐HSCT ALL spares unnecessary therapeutic interventions triggered by borderline qPCR results without an increase in relapse risk 2025 ·HemaSphere ·(unknown), Michael Svatoň, (unknown), (unknown), (unknown), (unknown), Petr Sedláček, (unknown), Renata Formánková, Petra Keslová, Lucie Šrámková, Jan Starý, Jan Zuna, Alexandra Kolenová, Cyril Šálek, Jan Trka, (unknown)	1
2	Rewired glutamate metabolism diminishes cytostatic action of L-asparaginase 2024 ·Cancer Letters ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Markéta Žaliová, (unknown), (unknown), Meritxell Alberich-Jordà, Jan Trka, Daniel A. Tennant, Júlia Starková	4
3	Minimal residual disease detection for acute lymphoblastic leukaemia in peripheral blood—Are we there yet? 2024 ·British Journal of Haematology ·Jan Trka, Eva Froňková	1
4	Novel molecular aberrations involved in testicular germ cell tumor (TGCT) development and cisplatin resistance. 2024 ·Journal of Clinical Oncology ·Ludmila Boublíková, (unknown), (unknown), (unknown), (unknown), Jan Stuchlý, (unknown), (unknown), Jan Trka	1
5	Near-tetraploid T-cell acute lymphoblastic leukaemia in childhood: Results of the AIEOP-BFM ALL studies 2022 ·European Journal of Cancer ·Francesco Ceppi, (unknown), Anja Möricke, Daniela Silvestri, (unknown), Jana Lentes, Anke Bergmann, Jan Trka, Julia Alten, (unknown), Draga Barbaric, Barbara Buldini, (unknown), Richard Fabian Schumacher, Gabriella Casazza, Joëlle Tchinda, Karin Nebral, Valentino Conter, Andishe Attarbaschi, Martin Schrappe	2
6	Two novel fusion genes, AIF1L‐ETV6 and ABL1‐AIF1L, result together with ETV6‐ABL1 from a single chromosomal rearrangement in acute lymphoblastic leukemia with prenatal origin 2018 ·Genes Chromosomes and Cancer ·(unknown), Eliška Potůčková, Lucie Šrámková, Jan Starý, Júlia Starková, Jan Trka, Felix Votava, Jan Zuna, Markéta Žaliová	4
7	Relapsed acute lymphoblastic leukemia-specific mutations in NT5C2 cluster into hotspots driving intersubunit stimulation 2018 ·Leukemia ·Aleš Hnı́zda, Milan Fábry, Takaya Moriyama, Petr Pachl, Michaël Kugler, (unknown), David B. Ascher, William L. Carroll, Petr Novák, Markéta Žaliová, Jan Trka, Pavlína Řezáčová, Jun J. Yang, Václav Veverka	24
8	CANCERTOOL: A Visualization and Representation Interface to Exploit Cancer Datasets 2018 ·Cancer Research ·Ana R. Cortázar, Verónica Torrano, Natalia Martín-Martín, Alfredo Caro‐Maldonado, Laura Camacho, Ivana Heřmanová, Elizabeth Guruceaga, L. Francisco Lorenzo‐Martín, Rubén Fernández, Roger R. Gomis, Iñigo Apaolaza, Vı́ctor Quesada, Jan Trka, Antonio Gómez‐Muñoz, (unknown), Xosé R. Bustelo, Francisco J. Planes, Ana M. Aransay, Arkaitz Carracedo	63
9	MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML 2017 ·Oncogene ·(unknown), (unknown), Askar Obulkasim, Daria G. Valerio, Edwin Sonneveld, (unknown), Válerie de Haas, Dirk Reinhardt, M Zimmermann, Jan Trka, André Baruchel, Rob Pieters, Marry M. van den Heuvel‐Eibrink, C. Michel Zwaan, Maarten Fornerod	14
10	Ikzf1 Deletion Status Discriminates For Outcome In Imatinibtreated Bcr-Abl1-Positive Childhood ALL 2013 ·Haematologica ·Arian van der Veer, Markéta Žaliová, Federica Mottadelli, Paola De Lorenzo, Geertruy te Kronnie, Christine J. Harrison, Hélène Cavé, Jan Trka, Saha, Martin Schrappe, Rob Pieters, Andrea Biondi, (unknown), Martin Stanulla, Monique L. den Boer, Giovanni Cazzaniga	1
11	Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase 2012 ·Experimental Hematology ·Ivana Heřmanová, Markéta Žaliová, Jan Trka, Júlia Starková	38
12	Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria 2010 ·Haematologica ·Ester Mejstříková, (unknown), Eva Froňková, (unknown), Tomáš Kalina, Jaroslav Štěrba, Y. Jabali, Vladimír Mihál, (unknown), (unknown), Dagmar Procházková, Jiří Hák, Zuzana Zemanová, Marie Jarošová, Alexandra Oltová, Petr Sedláček, (unknown), Jan Zuna, Jan Trka, Jan Starý, Ondřej Hrušák	42
13	[Treatment of adult acute lymphoblastic leukemia according to GMALL 07/2003 study protocol in the Czech Republic - the first experience]. 2010 ·PubMed ·(unknown), Cyril Šálek, (unknown), (unknown), (unknown), Jan Trka, (unknown), Jan Vydra, Tomáš Kozák, Jan M. Horáček, Павел Зак, Petr Cetkovský, Dieter Hoelzer, Jiřı́ Mayer	7
14	Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia 2009 ·Blood ·Iris H.I.M. Hollink, Marry M. van den Heuvel‐Eibrink, Martin Zimmermann, Brian V. Balgobind, Susan T.C.J.M. Arentsen-Peters, Mariëlle Alders, André Willasch, Gertjan J.L. Kaspers, Jan Trka, André Baruchel, Siebold S.N. de Graaf, Ursula Creutzig, Rob Pieters, Dirk Reinhardt, C. Michel Zwaan	80
15	Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of “isolated” and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group 2007 ·Blood ·Nikola Hagedorn, Cécile Acquaviva, Eva Froňková, Arend von Stackelberg, Andrea Barth, Udo zur Stadt, André Schrauder, Jan Trka, Nathalie Gaspar, Karl Seeger, Günter Henze, Hélène Cavé, Cornelia Eckert	53
16	Lymphoid Differentiation Pathways Can Be Traced by TCR δ Rearrangements 2005 ·The Journal of Immunology ·Eva Froňková, Ondřej Krejčí, Tomáš Kalina, Ondřej Horváth, Jan Trka, Ondřej Hrušák	22
17	NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms. 2004 ·PubMed ·(unknown), Martin Schrappe, Sabine Strehl, Alfred Reiter, Holger-Andreas Elsner, Jan Trka, Gunnar Cario, Susanne Viehmann, Jochen Harbott, Arndt Borkhardt, Markus Metzler, Thorsten Langer, Reinald Repp, Rolf Marschalek, Karl Welte, Oskar A. Haas, Martin Stanulla	29
18	Cutting Edge: TCR δ Gene Is Frequently Rearranged in Adult B Lymphocytes 2003 ·The Journal of Immunology ·Ondřej Krejčí, (unknown), Ondřej Horváth, Jan Trka, Ondřej Hrušák	17
19	[Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia]. 1999 ·PubMed ·Jan Trka, Jan Zuna, C Haškovec, (unknown), Markéta Kalinová, Kateřina Mužíková, (unknown), Ondřej Hrušák, Zuzana Zemanová, K Michalová, Jan Starý	6
20	TEL/AML1 positivity in childhood ALL: average or better prognosis? 1999 ·Leukemia ·Jan Zuna, Ondřej Hrušák, Markéta Kalinová, Kateřina Mužíková, Jan Starý, Jan Trka, (unknown)	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact